Oncotarget Continues To Progress in Its Influence
Oncotarget, originally started in 2010, is a traditional journal that carries multiple disciplines.
In 2010, Oncotarget was started originally focused on the subject of oncology, the study and science of the prevention of aliments. Oncotarget has taken a peculiar focus in regards to cancer.
Oncotarget stands out from other traditional journal by utilizing its own core values with the approach of advancing oncology: democratization.
Oncotarget supports democratization by allowing researchers to take advantage of the Creative Commons Attribution 3.0 License.
This allowance and democratization of permission allows researchers to actively collaborate information and archive their published research papers throughout the scientific community that is involved with oncology or its related subjects.
Due to this democratized, permissionless approach that Oncotarget embraces, more studies were able to be conducted at a much faster rate.
Oncotarget has also branch away from just solely oncology. The journal has gradually moved to other related topics such as chromosomes, autophagy, immunology, and other topics of interest. Learn more about Oncotarget at researchgate.net
Oncotarget’s Accomplishments with the Media
Oncotarget continues its momentum by gaining influence and notability altogether.
Oncotarget has been transformed from a weekly publication to a twice-weekly publication that enables readers to be able to receive two issues on the same week consistently on both Tuesday and Friday.
This gives readers the option to stay up-to-date on the current updates that is occuring throughout the Oncotarget community.
The second benefit is this is to avoid hiatuses and any odd future delays.
With publication adopting a twice-weekly publication schedule, Oncotarget had to adopt its mission towards its podcasting goal: starting it. Visit Oncotarget’s profile page at Facebook.
The purpose of Oncotarget as a podcast is to present information in a more easier method that can be more easily digested.
Listeners can listen to Oncotarget on Soundcloud, iTunes, Stitcher, and Player. FM.
Other Noteworthy Achievements
Oncotarget continues to be active in its own accomplishments.
One such accomplishment that needs to be recognized is that Oncotarget is the world’s largest known oncology journal.
Oncotarget carries an impact factor score of 5.168.
This journal is growing in influence and impact.
Another amazing accomplishment is that Oncotarget researchers have been able to classify novel therapeutic strategies to treat thyroid cancer.
Oncotarget is still remaining indexed by most scientific databases such as Embase, Scopus, Journal Citation Reports/Science Edition, Embase, BIOSIS Previews, and Biological Abstracts.
Oncotarget’s accomplishments have been rather astounding.
Moving Forward with Democratization
Due to its democratization principle, Oncotarget is entirely focused on moving the study on oncology to one day prevent cancer.